Literature DB >> 33787862

Autoimmune hypoglycemia expands the biological spectrum of HHV8+ multicentric Castleman disease.

Pierre Arnautou1, Martine Auclair2, Soraya Fellahi3, Clara Bouché4, Claire Fieschi1,5, Elias Barrak6, Viviane Queyrel-Moranne7, Lucy Chaillous6, Nicolas Blin6, Marion Malphettes1,5, Jehane Fadlallah1,5, Remi Bertinchamp1,5, Laurence Gérard1,5, Djaouida Bengoufa8, Lionel Galicier1,5, Eric Oksenhendler1,5, Corinne Vigouroux2,9,10, David Boutboul1,5,11.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33787862      PMCID： PMC8045508          DOI： 10.1182/bloodadvances.2020002801

Source DB:  PubMed          Journal:  Blood Adv        ISSN： 2473-9529


× No keyword cloud information.
  20 in total

1.  Rituximab therapy for the type B syndrome of severe insulin resistance.

Authors:  Anthony P Coll; Stephen Thomas; Ghulam J Mufti
Journal:  N Engl J Med       Date:  2004-01-15       Impact factor: 91.245

2.  Treatment of type B insulin resistance: a novel approach to reduce insulin receptor autoantibodies.

Authors:  R Malek; A Y Chong; B C Lupsa; A O Lungu; E K Cochran; M A Soos; R K Semple; J E Balow; P Gorden
Journal:  J Clin Endocrinol Metab       Date:  2010-05-19       Impact factor: 5.958

3.  Autoimmune thrombotic thrombocytopenic purpura associated with HHV8-related Multicentric Castleman disease.

Authors:  Jonathan London; David Boutboul; Felix Agbalika; Paul Coppo; Agnès Veyradier; Laurence Gérard; Eric Oksenhendler; Elie Azoulay; Lionel Galicier
Journal:  Br J Haematol       Date:  2016-05-25       Impact factor: 6.998

4.  Type B insulin resistance complicated with systemic lupus erythematosus.

Authors:  Shin-Ya Kawashiri; Atsushi Kawakami; Keita Fujikawa; Naoki Iwamoto; Toshiyuki Aramaki; Mami Tamai; Hideki Nakamura; Tomoki Origuchi; Hiroaki Ida; Katsumi Eguchi
Journal:  Intern Med       Date:  2010-03-01       Impact factor: 1.271

5.  KSHV infects a subset of human tonsillar B cells, driving proliferation and plasmablast differentiation.

Authors:  Lynn M Hassman; Thomas J Ellison; Dean H Kedes
Journal:  J Clin Invest       Date:  2011-01-18       Impact factor: 14.808

6.  Prospective study of rituximab in chemotherapy-dependent human immunodeficiency virus associated multicentric Castleman's disease: ANRS 117 CastlemaB Trial.

Authors:  Laurence Gérard; Alice Bérezné; Lionel Galicier; Véronique Meignin; Martine Obadia; Nathalie De Castro; Christine Jacomet; Renaud Verdon; Isabelle Madelaine-Chambrin; Emmanuelle Boulanger; Sylvie Chevret; Felix Agbalika; Eric Oksenhendler
Journal:  J Clin Oncol       Date:  2007-08-01       Impact factor: 44.544

7.  Clinical disorders associated with autoantibodies to the insulin receptor. Simulation by passive transfer of immunoglobulins to rats.

Authors:  R F Dons; R Havlik; S I Taylor; K L Baird; S S Chernick; P Gorden
Journal:  J Clin Invest       Date:  1983-09       Impact factor: 14.808

8.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease.

Authors:  J Soulier; L Grollet; E Oksenhendler; P Cacoub; D Cazals-Hatem; P Babinet; M F d'Agay; J P Clauvel; M Raphael; L Degos
Journal:  Blood       Date:  1995-08-15       Impact factor: 22.113

9.  IgG1 plasmacytosis in interleukin 6 transgenic mice.

Authors:  S Suematsu; T Matsuda; K Aozasa; S Akira; N Nakano; S Ohno; J Miyazaki; K Yamamura; T Hirano; T Kishimoto
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

10.  Primary B Lymphocytes Infected with Kaposi's Sarcoma-Associated Herpesvirus Can Be Expanded In Vitro and Are Recognized by LANA-Specific CD4+ T Cells.

Authors:  Samantha M Nicol; Shereen Sabbah; Kevin F Brulois; Jae U Jung; Andrew I Bell; Andrew D Hislop
Journal:  J Virol       Date:  2016-03-28       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.